Hungarian pharmacutical producer Human has recorded net profits of 674.1million forint ($3.4 million) on sales of 12.34 billion forint in the first nine months of 1997, an increase of 28.6% on the corresponding period of last year, according to MTI Econews.
The firm's domestic turnover was 10.73 billion forint, up 22.8%, while exports rose 85.5% to 1.67 billion forint. The increase in exports was attributed to a rise in orders for biochemicals contract work and higher sales of insulin and infusion liquids. In anticipation of further growth in exports, Human has started registering its products in the Czech and Slovak Republics, as well as in Romania, Russia and Lithuania.
Human's third-quarter sales of 4.46 billion forint were less than average as a result of the usual low level of demand for drugs during that period.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze